A carregar...
Use of the Etonogestrel Implant and Levonorgestrel Intrauterine Device Beyond the U.S. Food and Drug Administration–Approved Duration
OBJECTIVE: To evaluate the effectiveness of the contraceptive implant and the 52mg hormonal intrauterine device (IUD) in women using the method beyond the current U.S. Food and Drug Administration–approved duration of 3 and 5 years respectively. METHODS: Women willing to continue using their implant...
Na minha lista:
| Publicado no: | Obstet Gynecol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4347947/ https://ncbi.nlm.nih.gov/pubmed/25730221 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/AOG.0000000000000690 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|